Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
AGENCY
HHS-NIH11
PROGRAM
Discretionary
AMOUNT
Up to $150K
CLOSES
Aug 11, 2027
Description
The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is sparse or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.
Eligibility
Private institutions of higher education; Public and State controlled institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification); For profit organizations other than small businesses; Public housing authorities/Indian housing authorities; State governments; Small businesses; County governments; City or township governments; Independent school districts; Native American tribal governments (Federally recognized); Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Special district governments
Contact
Additional details
- Funding instrument
- Grant
- Cost sharing required
- No
- Archived
- Sep 16, 2027
Opportunity number: PAR-25-101
Search this number on Grants.gov for the official listing.